NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)

Testosterone undecanoate 1000 mg (4 ml) i.m. injection at baseline, at week 6, at week 18, at week 30 and at week 42, respectively

Matching placebo i.m. injections at baseline, at week 6, at week 18 at week 30 and at week 42, respectively